Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection

Liver Int. 2007 Oct;27(8):1134-43. doi: 10.1111/j.1478-3231.2007.01518.x.

Abstract

Background: Two receptor chains, IL-10RA and IL-10RB, are known to mediate the functions of interleukin-10 (IL-10), which has been shown to be involved in the progression of persistent hepatitis C virus (HCV) infection. Little information is available on the role of host genetic variation in IL-10 receptor genes and outcome of HCV infection. IL-22, an IL-10 homologue, shares the IL-10RB receptor chain with IL-10 and has antiviral properties. We investigated the possible role of polymorphisms in the IL-10RA and IL-22 genes in hepatitis C disease pathogenesis.

Methods: This study population consisted of 631 HCV patients, recruited from several hepatology clinics across Europe. We genotyped four single-nucleotide polymorphisms (SNPs) in the IL-10RA and six SNPs in the IL-22 gene by ligation detection reaction or restriction fragment length polymorphism. Outcome of HCV infection was assessed according to viral clearance, treatment response, severity of fibrosis and overall inflammation.

Conclusions: Variation in IL-10RA appeared to be correlated with response to treatment and inflammation. Two SNPs in IL-22 affected treatment response and viral clearance respectively. We furthermore report on allele and haplotype frequencies and linkage disequilibrium for IL-10RA and IL-22. Our results indicate that genetic variation in these genes may play a modulatory role in the outcome of hepatitis C infection.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Case-Control Studies
  • DNA Mutational Analysis
  • Europe
  • Female
  • Gene Frequency
  • Haplotypes
  • Hepatitis C / drug therapy*
  • Hepatitis C / genetics
  • Humans
  • Interleukin-10 Receptor alpha Subunit / genetics*
  • Interleukin-22
  • Interleukins / genetics*
  • Linkage Disequilibrium
  • Male
  • Polymorphism, Single Nucleotide*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interleukin-10 Receptor alpha Subunit
  • Interleukins